NCT04736693View on ClinicalTrials.gov

Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

18,028

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Osteoporosis
Interventions
DRUG

Raloxifene

Raloxifene dispensing claim is used as the reference group.

DRUG

Zoledronic Acid

Zoledronic Acid dispensing claim is used as the exposure group.

Trial Locations (1)

02120

Brigham And Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04736693 - Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter